Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment

9 Oct 2018 08:23

RNS Number : 3946D
Applied Graphene Materials PLC
09 October 2018
 

Applied Graphene Materials plc

("Applied Graphene Materials", "the Group" or "the Company")

Board Appointment

Applied Graphene Materials, the producer of specialty graphene materials, announces the appointment of David Jonathan Blain, aged 56, to the Board as Chief Financial Officer of the Company, with effect from 22nd October 2018. David is a chartered accountant with over 30 years' experience, who having worked in practice with Price Waterhouse has operated for many years at Board level in both fully listed and AIM companies.

David joins AGM from Nanoco Group plc, a nanotechnology business specialising in semiconductor material licences and products for the display, lighting and bio diagnostic imaging markets, where he operated as Chief Financial Officer and Company Secretary. During his time at Nanoco David led the finance team and, in addition to overseeing day to day finance functions, successfully completed an £8 million fundraise in November 2017. Prior to this he spent seven years at Inspired Capital plc (formerly Renovo Group plc), a fully listed biotech company which, following cessation of biotech activities, acquired a company lending funds to small businesses. Operating as CFO and Company Secretary he played a significant role in the acquisition of Ultimate Finance Group plc. During his tenure the business increased its market capitalisation to £150m, employing 170 staff prior to its takeover by Tavistock in 2015.

The appointment of David comes at a period of significant planned development for the Company as it looks to generate and secure additional and ever larger orders.

Adrian Potts Chief Executive Officer, commented:

"We are delighted to welcome David to Applied Graphene Materials. His extensive commercial and operational experience coupled with his background in an early stage nanotechnology business will be a huge asset to the Company as it moves into the next phase of development. Additionally, having spent a considerable amount of time working in manufacturing and listed companies, setting strategy and growing businesses and teams we believe this will be of significant benefit as we look to advance the Company."

ADDITIONAL INFORMATION

Other than as set out below, there is no further information to be disclosed under schedule 2(g) and Rule 17 of the AIM Rules in respect of Mr Blain's appointment.

Mr David Jonathan Blain, aged 56 is, or has been, a director of the following companies during the previous five years:

Current directorships/partnerships

Past directorships/partnerships

 

· Blain Associates Limited

 

 

· Nanoco Group Plc

· Nanoco Technologies Limited

· Nanoco Tech Limited

· Nanoco Life Sciences Limited

· Nanoco 2D Material Limited

· Dysons Sales Ledger Management Services Limited

· Ultimate Construction Finance Limited

· Ultimate Business Finance Limited

· Ultimate Finance Group Limited

· Ultimate Accelerated Payments Limited

· Ultimate Factors Limited

· Ultimate Bridging Finance Limited

· Ultimate Asset Financing Limited

· Ultimate Finance Limited

· Ultimate Trade Finance Limited

· Ultimate Finance Holdings Limited

· Ashley Finance Limited

· BIZHELP24 Limited

· Renovo Technologies Limited

· Renovo Ltd

· Broken Nation Films Ltd

· Reinnervate Limited

 

 

Ends

 

For further information, please contact:

 

Applied Graphene Materials +44 (0) 1642 438 214

Adrian Potts Chief Executive Officer

 

N+1 Singer +44 (0) 207 496 3000

Richard Lindley / James White

 

Hudson Sandler +44 (0) 207 796 4133

Charlie Jack / Emily Dillon

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFSFSWUFASEES
Date   Source Headline
11th Jan 20163:36 pmRNSDirector/PDMR Shareholding
8th Jan 201612:13 pmRNSResult of Meeting
18th Dec 20157:00 amRNSPlacing and Open Offer
16th Nov 20157:00 amRNSFull Year Results
23rd Oct 20157:00 amRNSJoint Development Agreements and Collaborations
21st Sep 20155:19 pmRNSHolding(s) in Company
18th Sep 20157:00 amRNSPeriod end trading update
9th Jul 20157:00 amRNSIssue of share options to Directors
30th Jun 20153:36 pmRNSHolding(s) in Company
17th Jun 20157:00 amRNSFirst Patent Approval
19th May 20154:40 pmRNSSecond Price Monitoring Extn
19th May 20154:35 pmRNSPrice Monitoring Extension
14th May 20157:00 amRNSPositive results from independent oil trials
27th Apr 20159:21 amRNSHolding(s) in Company
22nd Apr 20154:44 pmRNSHolding(s) in Company
22nd Apr 20153:28 pmRNSHolding(s) in Company
21st Apr 20154:46 pmRNSHolding(s) in Company
17th Apr 20157:00 amRNSPositive results from independent coatings trials
2nd Apr 20159:46 amRNSHolding(s) in Company
1st Apr 20154:39 pmRNSHolding(s) in Company
25th Mar 20157:00 amRNSInterim Results
3rd Feb 20157:00 amRNSTrading Update
27th Jan 201511:25 amRNSIssue of equity and total voting rights
22nd Jan 20157:00 amRNSSenior Management Appointments
22nd Dec 20147:00 amRNSDirectorate Change
15th Dec 201411:36 amRNSResult of AGM
15th Dec 20147:00 amRNSAGM Statement
24th Nov 20147:00 amRNSPosting of Annual Report and Notice of AGM
17th Nov 20147:00 amRNSInvestor site visit
5th Nov 20147:00 amRNSAppointment of Non-Executive Director
5th Nov 20147:00 amRNSFull Year Results
5th Sep 20147:00 amRNSPre-close update
28th Jul 20147:00 amRNSIssue of share options to Directors
9th Jul 201410:17 amRNSGrant of Options to Directors
2nd Jul 20144:36 pmRNSHolding(s) in Company
23rd May 20143:08 pmRNSIssue of Share Options
30th Apr 20143:40 pmRNSReplacement - Holding(s) in Company
28th Apr 20148:50 amRNSHolding(s) in Company
1st Apr 20147:00 amRNSAppointment of Non Executive Director
1st Apr 20147:00 amRNSInterim Results
19th Mar 20147:00 amRNSNotice of Interim Results
18th Mar 201411:00 amRNSDirectorate Change
20th Jan 20144:39 pmRNSHolding(s) in Company
15th Jan 201410:59 amRNSIssue of Equity
27th Nov 20134:40 pmRNSSecond Price Monitoring Extn
27th Nov 20134:35 pmRNSPrice Monitoring Extension
26th Nov 20134:40 pmRNSSecond Price Monitoring Extn
26th Nov 20134:35 pmRNSPrice Monitoring Extension
22nd Nov 201312:39 pmRNSHolding(s) in Company
20th Nov 20137:00 amRNSAdmission and First Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.